…
Lifeway Foods, Inc. produces and markets probiotic-based products in the United States and internationally. Its primary product is drinkable kefir, a cultured dairy product in various organic and non-organic sizes, flavors, and types. The company offers European-style soft cheeses; cream and other products; ProBugs, a line of kefir products designed for children; drinkable yogurt; and fresh made butter and sour cream. It sells its products under the Lifeway, GlenOaks Farms, and Fresh Made brand names, as well as under private labels on behalf of customers primarily through direct sales force, brokers, and distributors. Lifeway Foods, Inc. was incorporated in 1986 and is based in Morton Grove, Illinois.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Lifeway Foods Inc produces and markets cultured dairy products—primarily kefir and other probiotic beverages and dairy-based spreads—sold through retail and foodservice channels. The company may benefit from growing consumer interest in gut health and probiotics, product innovation, and expanded distribution, which could support longer-term revenue growth and strengthen its niche brand position.
Material risks include intense competition from larger food and beverage companies and plant-based alternatives, sensitivity to dairy commodity and input-cost swings, and execution risk tied to distribution and scale.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | 5.62M | 5.62M | 4.83M | 1.24M | -3.31M |
| Net income | 3.31M | 3.31M | 3.23M | 0.45M | -3.09M |
| Selling general administrative | 11.61M | 22.71M | 11.66M | 12.83M | 13.62M |
| Selling and marketing expenses | 11.10M | - | 10.20M | 11.06M | 13.48M |
| Gross profit | 28.71M | 28.71M | 26.93M | 22.15M | 25.86M |
| Reconciled depreciation | 2.97M | 2.87M | 3.24M | 3.34M | 3.48M |
| Ebit | 5.88M | 5.88M | 4.92M | -1.85M | -1.85M |
| Ebitda | 8.69M | 8.61M | 8.21M | 1.49M | 1.63M |
| Depreciation and amortization | 2.81M | - | 3.29M | 3.34M | 3.48M |
| Non operating income net other | -0.24M | - | 0.02M | 3.42M | 0.07M |
| Operating income | 5.88M | 5.88M | 4.92M | -1.85M | -3.11M |
| Other operating expenses | 113.19M | - | 97.10M | 95.59M | 105.22M |
| Interest expense | 0.12M | 0.12M | 0.12M | 0.25M | 0.27M |
| Tax provision | 0.92M | 2.31M | 1.60M | 0.78M | -0.23M |
| Interest income | - | - | - | 2.90M | 0.27M |
| Net interest income | -0.27M | -0.12M | -0.12M | -0.25M | -0.27M |
| Extraordinary items | - | - | - | - | 0.04M |
| Non recurring | - | - | - | - | 1.24M |
| Income tax expense | 2.31M | 2.31M | 1.60M | 0.78M | -0.23M |
| Total revenue | 119.06M | 119.06M | 102.03M | 93.66M | 103.35M |
| Total operating expenses | 22.83M | 113.19M | 22.01M | 24.08M | 27.72M |
| Cost of revenue | 90.36M | 90.36M | 75.09M | 71.51M | 77.49M |
| Total other income expense net | -0.26M | -0.15M | -0.10M | 3.08M | -1.17M |
| Net income from continuing ops | 0.92M | 3.31M | 3.23M | 0.45M | -3.09M |
| Net income applicable to common shares | 0.92M | 3.31M | 3.23M | 0.45M | -3.09M |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 82.64M | 70.87M | 70.87M | 60.07M | 56.99M |
| Intangible assets | 6.90M | 7.98M | 7.98M | 3.70M | 3.85M |
| Other current assets | 2.02M | 1.25M | 1.25M | 1.16M | 1.60M |
| Total liab | 22.20M | 21.74M | 21.74M | 13.21M | 13.74M |
| Total stockholder equity | 60.44M | 49.13M | 49.13M | 46.85M | 43.25M |
| Deferred long term liab | - | 3.03M | - | 1.76M | 0.92M |
| Other current liab | 4.84M | 4.32M | 0.72M | 2.67M | 3.96M |
| Common stock | 6.51M | 6.51M | 6.51M | 6.51M | 6.51M |
| Capital stock | 6.51M | 6.51M | 6.51M | 6.51M | 6.51M |
| Retained earnings | 65.80M | 53.51M | 53.51M | 50.20M | 46.96M |
| Other liab | - | 3.03M | 3.35M | 1.84M | 0.98M |
| Good will | 11.70M | 11.70M | 11.70M | 9.12M | 9.12M |
| Other assets | - | - | - | - | 1.80M |
| Cash | 13.20M | 9.23M | 9.23M | 7.93M | 3.84M |
| Total current liabilities | 16.62M | 12.06M | 12.06M | 8.44M | 9.52M |
| Current deferred revenue | 0.47M | - | - | 1.76M | - |
| Net debt | -10.27M | -1.77M | - | -4.81M | -0.32M |
| Short term debt | 1.32M | 1.13M | - | 0.18M | 0.28M |
| Short long term debt | 1.25M | 1.25M | 1.00M | - | - |
| Short long term debt total | 2.92M | 7.46M | - | 3.11M | 3.52M |
| Other stockholder equity | -11.87M | -10.88M | - | -9.85M | -10.22M |
| Property plant equipment | - | 20.91M | 20.35M | 21.39M | 22.27M |
| Total current assets | 38.20M | 29.05M | 29.05M | 24.05M | 19.20M |
| Net tangible assets | - | 28.43M | 29.45M | 34.03M | 30.27M |
| Short term investments | - | 5.00M | - | 3.56M | 2.72M |
| Net receivables | 13.88M | 10.27M | 10.27M | 8.03M | 7.37M |
| Long term debt | 1.48M | 5.25M | 6.25M | 2.77M | 2.75M |
| Inventory | 9.10M | 8.29M | 8.29M | 6.93M | 6.39M |
| Accounts payable | 9.98M | 6.61M | 6.61M | 5.59M | 5.28M |
| Accumulated other comprehensive income | - | - | - | - | -29.28M |
| Common stock total equity | - | 6.51M | - | 6.51M | 6.51M |
| Retained earnings total equity | - | 54.43M | - | 50.20M | 46.96M |
| Treasury stock | - | - | - | -12.45M | -12.60M |
| Non currrent assets other | 0.10M | 1.80M | 1.80M | 1.80M | 1.80M |
| Non current assets total | 44.45M | 41.83M | 41.83M | 36.02M | 37.79M |
| Capital lease obligations | 0.19M | 0.17M | 0.22M | 0.34M | 0.77M |
| Long term debt total | - | 5.25M | - | 2.77M | 2.75M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Investments | -4.03M | -7.14M | -1.89M | 1.49M | -2.72M |
| Change to liabilities | 1.65M | 1.02M | 0.31M | 1.52M | -3.33M |
| Total cashflows from investing activities | -4.03M | -7.14M | -1.89M | 0.84M | -2.72M |
| Net borrowings | -0.75M | 4.50M | 4.50M | -3.27M | -0.30M |
| Total cash from financing activities | 2.88M | 2.88M | -0.41M | -3.81M | -1.68M |
| Change to operating activities | 0.24M | 0.41M | -0.85M | 0.24M | -0.94M |
| Net income | 3.31M | 3.31M | 3.23M | 0.45M | -3.09M |
| Change in cash | 1.31M | 1.31M | 4.09M | 0.84M | -1.98M |
| Begin period cash flow | 7.93M | 7.93M | 3.84M | 3.00M | 4.98M |
| End period cash flow | 9.23M | 9.23M | 7.93M | 3.84M | 3.00M |
| Total cash from operating activities | 5.56M | 5.56M | 6.38M | 3.81M | 2.42M |
| Depreciation | 2.87M | 2.87M | 3.24M | 3.34M | 3.48M |
| Other cashflows from investing activities | -0.58M | - | 0.01M | 0.52M | 0.10M |
| Change to inventory | -1.36M | -1.36M | -0.54M | -0.52M | 1.32M |
| Change to account receivables | -1.93M | -1.93M | -1.30M | -0.42M | 2.38M |
| Sale purchase of stock | -1.58M | -1.58M | -0.41M | -0.54M | -1.38M |
| Other cashflows from financing activities | 4.97M | -0.03M | -1.89M | 0.84M | 5.98M |
| Change to netincome | 1.18M | 1.47M | 1.15M | -2.00M | 2.13M |
| Capital expenditures | 1.92M | 1.92M | 1.90M | 1.18M | 2.82M |
| Change receivables | -1.48M | - | -1.30M | -0.42M | 2.38M |
| Cash flows other operating | 0.08M | - | 0.98M | 1.44M | -0.48M |
| Cash and cash equivalents changes | -4.79M | - | 4.09M | 0.84M | -1.98M |
| Change in working capital | -2.09M | -2.09M | -1.24M | 2.12M | -0.01M |
| Stock based compensation | 1.14M | 1.14M | 0.39M | 0.84M | 0.80M |
| Other non cash items | 0.07M | -0.02M | -0.08M | -3.47M | 1.69M |
| Free cash flow | 3.64M | 3.64M | 4.49M | 2.63M | -0.41M |
Sector: Consumer Defensive Industry: Packaged Foods
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| LWAY Lifeway Foods Inc |
-0.65 2.89% |
21.86 | 18.15 | - | 1.90 | 5.03 | 1.83 | 14.54 |
| NSRGF Nestle SA |
- -% |
101.69 | 26.86 | 18.76 | 3.13 | 7.10 | 3.81 | 21.70 |
| NSRGY Nestle SA ADR |
0.07 0.07% |
103.51 | 26.82 | 18.66 | 3.18 | 7.07 | 3.81 | 21.70 |
| DANOY Danone PK |
0.23 1.52% |
15.40 | 24.23 | 17.64 | 1.88 | 2.57 | 1.88 | 11.70 |
| GPDNF Danone S.A |
- -% |
75.00 | 20.30 | 14.75 | 1.65 | 2.24 | 1.76 | 10.92 |
Lifeway Foods, Inc. produces and markets probiotic-based products in the United States and internationally. Its primary product is drinkable kefir, a cultured dairy product in various organic and non-organic sizes, flavors, and types. The company offers European-style soft cheeses; cream and other products; ProBugs, a line of kefir products designed for children; drinkable yogurt; and fresh made butter and sour cream. It sells its products under the Lifeway, GlenOaks Farms, and Fresh Made brand names, as well as under private labels on behalf of customers primarily through direct sales force, brokers, and distributors. Lifeway Foods, Inc. was incorporated in 1986 and is based in Morton Grove, Illinois.
6431 West Oakton Street, Morton Grove, IL, United States, 60053
847 967 1010
288
| Name | Title | Year Born |
|---|---|---|
| Ms. Julie Smolyansky | CEO, Pres, Sec. & Chairperson of the Board | 1975 |
| Mr. Eric A. Hanson | CFO, Chief Accounting Officer & Treasurer | 1975 |
| Ms. Amy M. Feldman | Sr. Exec. VP of Sales | 1976 |
| Ms. Julie Smolyansky | Chairperson of the Board, CEO, President & Secretary | 1975 |
| Ms. Amy M. Feldman | Senior Executive Vice President of Sales | 1976 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.